Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST StudyHideki Ueno, Masao Tanaka, Hiroaki Yanagimoto et al.|Journal of Clinical Oncology|2013Cited by 632
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 studyHedy L. Kindler, Eric Van Cutsem, Tatsuya Ioka et al.|The Lancet Oncology|2011Cited by 396